Login to Your Account

Financings Roundup

Friday, February 22, 2013
• Novelos Therapeutics, Inc., of Madison, Wisc., said it closed a public offering of 11 million units at $0.50 per unit for gross proceeds of $5.5 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription